E030 Demyelinating neurological adverse events following the use of adalimumab
Gharib, Miral H, Alemadi, Samar A, Al-Allaf, Abdul-Wahab, Abdulaziz, Hani MVolume:
58
Language:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/kez110.029
Date:
April, 2019
File:
PDF, 60 KB
english, 2019